Kathleen P. Gallagher insider trades

Open-market stock purchases and sales by Kathleen P. Gallagher, See Remarks at Atrium Therapeutics, Inc, from SEC Form 4 filings since Jan 6, 2025.

Recent trades

DateStockTradeValue
Sep 18, 2026RNA Atrium Therapeutics, IncSold (not open market)$104K
Apr 20, 2026RNA Atrium Therapeutics, IncBought (not open market)—
Apr 20, 2026RNA Atrium Therapeutics, IncBought (not open market)—
Feb 27, 2026RNAM Avidity Biosciences, IncSold (not open market)$154K
Feb 27, 2026RNAM Avidity Biosciences, IncSold (not open market)$222K
Feb 27, 2026RNAM Avidity Biosciences, IncSold (not open market)$620K
Feb 27, 2026RNAM Avidity Biosciences, IncSold (not open market)$350K
Feb 27, 2026RNAM Avidity Biosciences, IncSold (not open market)$137K
Feb 27, 2026RNAM Avidity Biosciences, IncSold (not open market)$704K
Feb 27, 2026RNAM Avidity Biosciences, IncSold (not open market)—
Feb 27, 2026RNAM Avidity Biosciences, IncSold (not open market)$561K
Feb 27, 2026RNAM Avidity Biosciences, IncSold (not open market)$203K
Feb 27, 2026RNAM Avidity Biosciences, IncSold (not open market)$1.6M
Dec 17, 2025RNA Avidity Biosciences, IncBought (not open market)—
Dec 17, 2025RNA Avidity Biosciences, IncSold (not open market)$2.4M
Dec 17, 2025RNA Avidity Biosciences, IncSold (not open market)$577K

Companies traded

  • RNA Atrium Therapeutics, Inc: 12 sales, last Sep 18, 2026
  • RNAM Avidity Biosciences, Inc: other filings, last Feb 27, 2026

Get free alerts when Kathleen P. Gallagher files a new trade →